0

Close
 
Upcoming Allied Market Research
2023
Artificial Vital Organs And Medical Bionics Market

Artificial Vital Organs and Medical Bionics Market

by Product Type (Artificial Vital Organs Market, Medical Bionics Market): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare
Report Code: A00270
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Artificial Vital Organs And Medical Bionics Market

Request Now !

Artificial organ is man-made machine or device that is used to replace the functions of missing or faulty organ and restores the functions of original organ. Medical bionics refers to the study of artificial body parts that are substituted for a natural biological capability. Healthcare technology is growing rapidly in which organ transplantation has evolved as common practice. There is a high demand from the patients for organ transplantation surgery, whereas availability of the donors to fulfill this demand is low. Due to this wider gap, artificial vital organs and medical bionics market is experiencing fair growth. The report provides an in-depth analysis of the different segments for artificial vital organs and medical bionics market and comprehensively determines the factors responsible for growth, major constraints and potential opportunities. Through analysis of leading company profiles and their strategies, professionals would gain the competitive edge in the market.

Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market. Some crucial factors restraining the growth of this market are high cost of devices and surgery, lack of surgical skills and uncertain reimbursement policies in some regions. Improvement in disposable incomes of end-users and increase in awareness could be the potential factors to fuel the growth of this market. Emerging economies have opened new avenues for the growth of this market, due to growing income levels, high healthcare expenditure and increase in awareness amongst the people about organ transplantation.

Artificial Vital Organs and Medical Bionics Market by Product Type

The artificial vital organs and medical bionics market is segmented by product type into two broad categories such as Artificial vital organs market and Medical bionics market. Artificial vital organs market is further categorized into different segments, namely artificial liver, artificial heart, artificial pancreas, artificial kidney, artificial lungs and oxygenators. Medical bionics market also consists of sub-segments and includes bionic limbs, vision bionics, ear bionics, exoskeletons, brain bionics, heart valves and cardiac bionics. In artificial vital organs market, artificial kidneys lead the market due to high incidence of acute renal failure. In medical bionics market, bionic exoskeleton accounts for high CAGR due to strong research initiatives in this segment. Artificial pancreases and bio-lungs are the pipeline devices in medical bionics market.

 Artificial Vital Organs and Medical Bionics Market by Application

The biochip products and services market is segmented by application type into different sub-categories such as gene sequencing and gene expression, clinical diagnosis and treatment (Cancer diagnosis), genomics and toxicogenomics, proteomics, drug discovery and other applications. Clinical diagnosis and treatment is the leading sub-segment in application types. Cancer diagnosis and treatment segment is primarily driven by personalized medicines approved by the FDA for the treatment of cancer. Other factor supportive to the growth of cancer diagnosis segment include government funding and technological advancements.

Artificial Vital Organs and Medical Bionics Market by Geography

Geographically, artificial vital organs and medical bionics market is segmented into North America, Europe, Asia and LAMEA. North America leads the artificial vital organs and medical bionics market followed by Europe. The reasons attributed for this growth include concentrated high income groups, aged population and high organ failure rates.  Asia- Pacific is emerging as a fastest growing market for artificial vital organs and medical bionics, due to growing income levels, government initiatives, raising healthcare awareness and high healthcare expenditure. 

Competitive Landscape

The leading companies in artificial vital organs and medical bionics market include Edwards Lifesciences Corporation, Abbott Diabetes Care, Inc., Baxter International, Inc., Ekso Bionics, Asahi Kasei Medical Co., Ltd., Jarvik Heart, Inc. and Ottobock Healthcare GmbH. Manufactures are now concentrating on the development of bionic implant products such as bio-lung, wearable artificial kidney, and artificial pancreas for diseases where alternative treatment methods are inefficient for cure.

High Level Analysis

In-depth analysis of market drivers, challenges and trends would be helpful to understand the market dynamics and serves as a guide for product positioning. Competitive landscape section entirely focuses on key players, new launches, and technological advancements within artificial vital organs and medical bionics market. Porter’s five forces analysis has been used to determine the attractiveness of artificial vital organs and medical bionics market. High demand for organ transplantation surgeries and lack of donors are the crucial factors that increase the bargaining power of suppliers. Low disposable incomes of consumers in developing economies reduce the bargaining power of buyers. Artificial vital organs and medical bionics products are highly differentiated due to their innovative features such as low battery warnings, gesture selection and auto grasp feature. Due to this product differentiation, threat of new entrant is low. High investment cost, which can be afforded by few big organizations, results in low intensity of rivalry.

KEY BENEFITS

  • This report offers the following benefits in particular:
  • Comprehensive coverage of artificial vital organs and medical bionics market along with market trends, drivers and restraints would be helpful to understand the market dynamics
  • Exhaustive analysis of different segments helps to recognize and exploit future opportunities within artificial vital organs and medical bionics market
  • In-depth assessment of leading company profiles, pipeline research and new launches would be informative to professionals in corporate sector
  • High level analysis section uses Porter’s five forces tool to analyze the market dynamics that would be beneficial for strategic decision makers   

 Artificial Vital Organs and Medical Bionics Market Report Highlights

Aspects Details
By Product Type
  • Artificial Vital Organs Market
    • Artificial Liver
    • Artificial Heart
    • Artificial Pancreas
    • Artificial Kidney
    • Artificial Lungs
    • Oxygenators
  • Medical Bionics Market
    • Bionic Limbs
    • Vision Bionics
    • Ear Bionics
    • Exoskeletons
    • Brain Bionics
    • Heart Valves
    • Cardiac Bionics
By GEOGRAPHY
  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Artificial Vital Organs Market

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Artificial Liver

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Artificial Heart

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Artificial Pancreas

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Artificial Kidney

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Artificial Lungs

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Oxygenators

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Medical Bionics Market

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Bionic Limbs

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Vision Bionics

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Ear Bionics

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Exoskeletons

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Brain Bionics

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Heart Valves

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Cardiac Bionics

        • 4.3.4.1. Market Size and Forecast

  • CHAPTER 5: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY REGION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Region

    • 5.2. North America

      • 5.2.1. Key Market Trends and Opportunities

      • 5.2.2. Market Size and Forecast, By Product Type

      • 5.2.3. Market Size and Forecast, By Country

      • 5.2.4. U.S. Artificial Vital Organs And Medical Bionics Market

        • 5.2.4.1. Market Size and Forecast, By Product Type

      • 5.2.5. Canada Artificial Vital Organs And Medical Bionics Market

        • 5.2.5.1. Market Size and Forecast, By Product Type

      • 5.2.6. Mexico Artificial Vital Organs And Medical Bionics Market

        • 5.2.6.1. Market Size and Forecast, By Product Type

    • 5.3. Europe

      • 5.3.1. Key Market Trends and Opportunities

      • 5.3.2. Market Size and Forecast, By Product Type

      • 5.3.3. Market Size and Forecast, By Country

      • 5.3.4. France Artificial Vital Organs And Medical Bionics Market

        • 5.3.4.1. Market Size and Forecast, By Product Type

      • 5.3.5. Germany Artificial Vital Organs And Medical Bionics Market

        • 5.3.5.1. Market Size and Forecast, By Product Type

      • 5.3.6. Italy Artificial Vital Organs And Medical Bionics Market

        • 5.3.6.1. Market Size and Forecast, By Product Type

      • 5.3.7. Spain Artificial Vital Organs And Medical Bionics Market

        • 5.3.7.1. Market Size and Forecast, By Product Type

      • 5.3.8. UK Artificial Vital Organs And Medical Bionics Market

        • 5.3.8.1. Market Size and Forecast, By Product Type

      • 5.3.9. Russia Artificial Vital Organs And Medical Bionics Market

        • 5.3.9.1. Market Size and Forecast, By Product Type

      • 5.3.10. Rest Of Europe Artificial Vital Organs And Medical Bionics Market

        • 5.3.10.1. Market Size and Forecast, By Product Type

    • 5.4. Asia-Pacific

      • 5.4.1. Key Market Trends and Opportunities

      • 5.4.2. Market Size and Forecast, By Product Type

      • 5.4.3. Market Size and Forecast, By Country

      • 5.4.4. China Artificial Vital Organs And Medical Bionics Market

        • 5.4.4.1. Market Size and Forecast, By Product Type

      • 5.4.5. Japan Artificial Vital Organs And Medical Bionics Market

        • 5.4.5.1. Market Size and Forecast, By Product Type

      • 5.4.6. India Artificial Vital Organs And Medical Bionics Market

        • 5.4.6.1. Market Size and Forecast, By Product Type

      • 5.4.7. South Korea Artificial Vital Organs And Medical Bionics Market

        • 5.4.7.1. Market Size and Forecast, By Product Type

      • 5.4.8. Australia Artificial Vital Organs And Medical Bionics Market

        • 5.4.8.1. Market Size and Forecast, By Product Type

      • 5.4.9. Thailand Artificial Vital Organs And Medical Bionics Market

        • 5.4.9.1. Market Size and Forecast, By Product Type

      • 5.4.10. Malaysia Artificial Vital Organs And Medical Bionics Market

        • 5.4.10.1. Market Size and Forecast, By Product Type

      • 5.4.11. Indonesia Artificial Vital Organs And Medical Bionics Market

        • 5.4.11.1. Market Size and Forecast, By Product Type

      • 5.4.12. Rest of Asia Pacific Artificial Vital Organs And Medical Bionics Market

        • 5.4.12.1. Market Size and Forecast, By Product Type

    • 5.5. LAMEA

      • 5.5.1. Key Market Trends and Opportunities

      • 5.5.2. Market Size and Forecast, By Product Type

      • 5.5.3. Market Size and Forecast, By Country

      • 5.5.4. Brazil Artificial Vital Organs And Medical Bionics Market

        • 5.5.4.1. Market Size and Forecast, By Product Type

      • 5.5.5. South Africa Artificial Vital Organs And Medical Bionics Market

        • 5.5.5.1. Market Size and Forecast, By Product Type

      • 5.5.6. Saudi Arabia Artificial Vital Organs And Medical Bionics Market

        • 5.5.6.1. Market Size and Forecast, By Product Type

      • 5.5.7. UAE Artificial Vital Organs And Medical Bionics Market

        • 5.5.7.1. Market Size and Forecast, By Product Type

      • 5.5.8. Argentina Artificial Vital Organs And Medical Bionics Market

        • 5.5.8.1. Market Size and Forecast, By Product Type

      • 5.5.9. Rest of LAMEA Artificial Vital Organs And Medical Bionics Market

        • 5.5.9.1. Market Size and Forecast, By Product Type

  • CHAPTER 6: COMPETITIVE LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top Winning Strategies

    • 6.3. Product Mapping Of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Top Player Positioning,2022

  • CHAPTER 7: COMPANY PROFILES

    • 7.1. Company 1

      • 7.1.1. Company Overview

      • 7.1.2. Key Executives

      • 7.1.3. Company Snapshot

      • 7.1.4. Operating Business Segments

      • 7.1.5. Product Portfolio

      • 7.1.6. Business Performance

      • 7.1.7. Key Strategic Moves and Developments

    • 7.2. Company 2

      • 7.2.1. Company Overview

      • 7.2.2. Key Executives

      • 7.2.3. Company Snapshot

      • 7.2.4. Operating Business Segments

      • 7.2.5. Product Portfolio

      • 7.2.6. Business Performance

      • 7.2.7. Key Strategic Moves and Developments

    • 7.3. Company 3

      • 7.3.1. Company Overview

      • 7.3.2. Key Executives

      • 7.3.3. Company Snapshot

      • 7.3.4. Operating Business Segments

      • 7.3.5. Product Portfolio

      • 7.3.6. Business Performance

      • 7.3.7. Key Strategic Moves and Developments

    • 7.4. Company 4

      • 7.4.1. Company Overview

      • 7.4.2. Key Executives

      • 7.4.3. Company Snapshot

      • 7.4.4. Operating Business Segments

      • 7.4.5. Product Portfolio

      • 7.4.6. Business Performance

      • 7.4.7. Key Strategic Moves and Developments

    • 7.5. Company 5

      • 7.5.1. Company Overview

      • 7.5.2. Key Executives

      • 7.5.3. Company Snapshot

      • 7.5.4. Operating Business Segments

      • 7.5.5. Product Portfolio

      • 7.5.6. Business Performance

      • 7.5.7. Key Strategic Moves and Developments

    • 7.6. Company 6

      • 7.6.1. Company Overview

      • 7.6.2. Key Executives

      • 7.6.3. Company Snapshot

      • 7.6.4. Operating Business Segments

      • 7.6.5. Product Portfolio

      • 7.6.6. Business Performance

      • 7.6.7. Key Strategic Moves and Developments

    • 7.7. Company 7

      • 7.7.1. Company Overview

      • 7.7.2. Key Executives

      • 7.7.3. Company Snapshot

      • 7.7.4. Operating Business Segments

      • 7.7.5. Product Portfolio

      • 7.7.6. Business Performance

      • 7.7.7. Key Strategic Moves and Developments

    • 7.8. Company 8

      • 7.8.1. Company Overview

      • 7.8.2. Key Executives

      • 7.8.3. Company Snapshot

      • 7.8.4. Operating Business Segments

      • 7.8.5. Product Portfolio

      • 7.8.6. Business Performance

      • 7.8.7. Key Strategic Moves and Developments

    • 7.9. Company 9

      • 7.9.1. Company Overview

      • 7.9.2. Key Executives

      • 7.9.3. Company Snapshot

      • 7.9.4. Operating Business Segments

      • 7.9.5. Product Portfolio

      • 7.9.6. Business Performance

      • 7.9.7. Key Strategic Moves and Developments

    • 7.10. Company 10

      • 7.10.1. Company Overview

      • 7.10.2. Key Executives

      • 7.10.3. Company Snapshot

      • 7.10.4. Operating Business Segments

      • 7.10.5. Product Portfolio

      • 7.10.6. Business Performance

      • 7.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ARTIFICIAL VITAL ORGANS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MEDICAL BIONICS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. NORTH AMERICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. NORTH AMERICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 7. U.S. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 8. CANADA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 9. MEXICO ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 10. EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 12. FRANCE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 13. GERMANY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 14. ITALY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. SPAIN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 16. UK ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. RUSSIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 18. REST OF EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 21. CHINA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. JAPAN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. INDIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 24. SOUTH KOREA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. AUSTRALIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. THAILAND ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 27. MALAYSIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. INDONESIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 29. REST OF ASIA PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 31. LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. BRAZIL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 33. SOUTH AFRICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. SAUDI ARABIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. UAE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. ARGENTINA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 37. REST OF LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. COMPANY 1: KEY EXECUTIVES
  • TABLE 39. COMPANY 1: COMPANY SNAPSHOT
  • TABLE 40. COMPANY 1: OPERATING SEGMENTS
  • TABLE 41. COMPANY 1: PRODUCT PORTFOLIO
  • TABLE 42. COMPANY 1: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 43. COMPANY 2: KEY EXECUTIVES
  • TABLE 44. COMPANY 2: COMPANY SNAPSHOT
  • TABLE 45. COMPANY 2: OPERATING SEGMENTS
  • TABLE 46. COMPANY 2: PRODUCT PORTFOLIO
  • TABLE 47. COMPANY 2: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 48. COMPANY 3: KEY EXECUTIVES
  • TABLE 49. COMPANY 3: COMPANY SNAPSHOT
  • TABLE 50. COMPANY 3: OPERATING SEGMENTS
  • TABLE 51. COMPANY 3: PRODUCT PORTFOLIO
  • TABLE 52. COMPANY 3: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 53. COMPANY 4: KEY EXECUTIVES
  • TABLE 54. COMPANY 4: COMPANY SNAPSHOT
  • TABLE 55. COMPANY 4: OPERATING SEGMENTS
  • TABLE 56. COMPANY 4: PRODUCT PORTFOLIO
  • TABLE 57. COMPANY 4: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 58. COMPANY 5: KEY EXECUTIVES
  • TABLE 59. COMPANY 5: COMPANY SNAPSHOT
  • TABLE 60. COMPANY 5: OPERATING SEGMENTS
  • TABLE 61. COMPANY 5: PRODUCT PORTFOLIO
  • TABLE 62. COMPANY 5: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 63. COMPANY 6: KEY EXECUTIVES
  • TABLE 64. COMPANY 6: COMPANY SNAPSHOT
  • TABLE 65. COMPANY 6: OPERATING SEGMENTS
  • TABLE 66. COMPANY 6: PRODUCT PORTFOLIO
  • TABLE 67. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 68. COMPANY 7: KEY EXECUTIVES
  • TABLE 69. COMPANY 7: COMPANY SNAPSHOT
  • TABLE 70. COMPANY 7: OPERATING SEGMENTS
  • TABLE 71. COMPANY 7: PRODUCT PORTFOLIO
  • TABLE 72. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 73. COMPANY 8: KEY EXECUTIVES
  • TABLE 74. COMPANY 8: COMPANY SNAPSHOT
  • TABLE 75. COMPANY 8: OPERATING SEGMENTS
  • TABLE 76. COMPANY 8: PRODUCT PORTFOLIO
  • TABLE 77. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. COMPANY 9: KEY EXECUTIVES
  • TABLE 79. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 80. COMPANY 9: OPERATING SEGMENTS
  • TABLE 81. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 82. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. COMPANY 10: KEY EXECUTIVES
  • TABLE 84. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 85. COMPANY 10: OPERATING SEGMENTS
  • TABLE 86. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 87. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 3. SEGMENTATION ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 11. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ARTIFICIAL VITAL ORGANS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MEDICAL BIONICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 18. COMPETITIVE DASHBOARD
  • FIGURE 19. COMPETITIVE HEATMAP: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
  • FIGURE 20. Top player positioning, 2022
  • FIGURE 21. COMPANY 1: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 22. COMPANY 1: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 23. COMPANY 1: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 24. COMPANY 2: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 25. COMPANY 2: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 26. COMPANY 2: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 27. COMPANY 3: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. COMPANY 3: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. COMPANY 3: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. COMPANY 4: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. COMPANY 4: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. COMPANY 4: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. COMPANY 5: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. COMPANY 5: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. COMPANY 5: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. COMPANY 6: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. COMPANY 6: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. COMPANY 7: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. COMPANY 7: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. COMPANY 8: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. COMPANY 8: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Artificial Vital Organs And Medical Bionics Market

Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers